1. Quality of guideline development assessed by the Evaluation Committee of the Japan Society of Clinical Oncology

   • Takuro Shimbo
   • Tsuguya Fukui
   • Koichi Hirata

   Special Article 24 March 2010 Pages: 227 - 233

   

2. Molecularly targeted therapy for hepatocellular carcinoma from the basic and clinical aspects

   • Shigeki Arii

   Introduction to Review Articles 27 May 2010 Pages: 234 - 234

3. Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science

   • Shinji Tanaka
   • Shigeki Arii

   Review Article 27 May 2010 Pages: 235 - 241

   

4. Current status of molecularly targeted therapy for hepatocellular carcinoma: clinical practice

   • Masatoshi Kudo

   Review Article 28 May 2010 Pages: 242 - 255

   

5. Out-of-pocket payment and cost-effectiveness of XELOX and XELOX plus bevacizumab therapy: from the perspective of metastatic colorectal cancer patients in Japan

   • Takeru Shiroiwa
   • Takashi Fukuda
   • Kiichiro Tsutani

   Original Article 04 March 2010 Pages: 256 - 262

   

6. Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients

   • Hiroyuki Komori
   • Toru Beppu
   • Hideo Baba

   Original Article 19 March 2010 Pages: 263 - 270

   

7. A pretreatment nomogram predicting recurrence- and progression-free survival for nonmuscle invasive bladder cancer in Japanese patients

   • Toru Yamada
   • Kunihiro Tsuchiya
   • Takashi Deguchi

   Original Article 02 March 2010 Pages: 271 - 279

   

8. Health-related quality of life in patients with advanced colorectal cancer: results from a phase II study of S-1 combined with irinotecan (CPT-11)

   • Akira Tsunoda
   • Naokuni Yasuda
   • Mitsuo Kusano

   Original Article 16 March 2010 Pages: 280 - 286

9. Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer: retrospective analysis

   • Takeshi Sakamoto
   • Hirofumi Yasui
   • Satoshi Hamauchi

   Original Article 10 March 2010 Pages: 287 - 293

   

10. Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer

    • Hisashi Imai
    • Ryuichiro Doi
    • Shinji Uemoto

    Original Article 16 March 2010 Pages: 294 - 300

    

11. Supraclavicular lymph node metastasis as the initial presentation of primary fallopian tube carcinoma

    • Nobuyuki Sakurai
    • Kazuhiro Tateoka
    • Kaneyuki Kubushiro

    Case Report 26 February 2010 Pages: 301 - 304

    

12. Head and neck sarcoma: report of a case treated by intensity-modulated radiation therapy

    • Pierre Heudel
    • Marie Claude Biston
    • Pascal Pommier

    Case Report 02 March 2010 Pages: 305 - 309

    

13. Complete response of anaplastic pancreatic carcinoma to paclitaxel treatment selected by chemosensitivity testing

    • Takeru Wakatsuki
    • Atsushi Irisawa
    • Hiromasa Ohira

    Case Report 02 March 2010 Pages: 310 - 313

    

14. Ewing’s sarcoma of the kidney

    • Joel R. Angel
    • Anushayanthan Alfred
    • Joseph John Zechlinski

    Case Report 04 March 2010 Pages: 314 - 318

    

15. A case of rapidly growing pulmonary carcinosarcoma

    • Shuichi Sato
    • Teruaki Koike
    • Hiroko Tsukada

    Case Report 10 March 2010 Pages: 319 - 324

    

16. Increased paclitaxel resistance in recurrent epithelial ovarian cancer: analysis of metachronous tumors

    • Koji Matsuo
    • Dwight D. Im
    • Neil B. Rosenshein

    Letter to the Editor 25 February 2010 Pages: 325 - 327

17. Arm port implantation in cancer patients

    • Pierre-Yves Marcy
    • Andrea Figl
    • Antoine Ianessi

    Letter to the Editor 02 March 2010 Pages: 328 - 330

    

18. Erratum to: Evaluation of S-1 as third- or further-line chemotherapy in advanced non-small-cell lung cancer

    • Akira Ono
    • Tateaki Naito
    • Nobuyuki Yamamoto

    Erratum 08 April 2010 Pages: 331 - 331